US82489T1043 - Common Stock - After market: 187.32 0 (0%)
NASDAQ:SWAV (2/3/2023, 7:09:57 PM)-2.17 (-1.15%)
|GICS Sector||Health Care|
|GICS Industry||Health Care Equipment & Supplies|
|Earnings (Last)||11-07 2022-11-07/amc||Earnings (Next)||02-15 2023-02-15|
|Ins Owners||1.48%||Inst Owners||91.39%|
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find more growth stocks the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Shockwave Medical, Inc. operates as a medical device company, which focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company is headquartered in Santa Clara, California and currently employs 657 full-time employees. The company went IPO on 2019-03-07. The firm is engaged in medical device treatment of atherosclerotic cardiovascular disease (atherosclerosis) through its differentiated local delivery of sonic pressure waves for the treatment of calcified plaque, which refer to as intravascular lithotripsy (IVL). Its products for the treatment of peripheral artery disease (PAD) includes Shockwave M5 IVL catheter (M5 catheter) and Shockwave S4 IVL catheter (S4 catheter). Its product for the treatment of coronary artery disease (CAD) is Shockwave C2 IVL catheter (C2 catheter). M5 catheter is a five-emitter catheter for use in its IVL System in medium vessels for the treatment of above-the-knee PAD. S4 catheter is a four-emitter catheter for use in its IVL System in small vessels for the treatment of below-the-knee PAD. C2 catheter is a two-emitter catheter for use in its IVL System for the treatment of CAD.
SHOCKWAVE MEDICAL INC
5403 Betsy Ross Dr
Santa Clara CALIFORNIA 95054
CEO: Douglas Godshall
Guidance Expands Number of Hospitals that Can Access IVL to Include Sites Where Calcium Modification Tools Were Previously Not Recommended
These pharma stocks all have excellent risk-reward ratios and the companies have developed treatments that could easily become blockbusters.
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.
These stocks are all down by at least 42% from their all-time highs despite impressive performances from their underlying businesses.
Bank of America reaffirmed its Buy rating on ShockWave Medical (SWAV) after its shares witnessed a sharp in reaction to a deal to acquire Neovasc (NVCN). Read the full story here.
Shockwave Medical (SWAV) is acquiring Neovasc (NVCN) for an enterprise value of ~$100M.Canada-based medical device maker Neovasc is developing a minimally invasive treatment for...
Here you can normally see the latest stock twits on SWAV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.